LP34573-3
Buprenorphine+Norbuprenorphine
Active
Description
Norbuprenorphine is the primary active metabolite of buprenorphine. Norbuprenorphine acts as a μ-opioid, δ-opioid, and nociceptin receptor full agonist, as well as a κ-opioid receptor partial agonist. Norbuprenorphine crosses the blood-brain-barrier similarly to buprenorphine and likely contributes to its effects. Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details. Source: Wikipedia, Buprenorphine+Norbuprenorphine
Basic Part Properties
- Part Name
- Buprenorphine+Norbuprenorphine
- Part Display Name
- Buprenorphine+Norbuprenorphine
- Part Type
- Component (Describes the core component or analyte measured)
- Created On
- 2004-09-03
- Construct for LOINC Short Name
- Buprenorphine+Nor
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
- CodeSystem lookup
- https:
//fhir.loinc.org/CodeSystem/$lookup?system=http: //loinc.org&code=LP34573-3
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
zh-CN | Chinese (China) | 丁丙诺啡+去甲基丁丙诺啡 |
fr-CA | French (Canada) | Buprénorphine+Norbuprénorphine |
et-EE | Estonian (Estonia) | Buprenorfiin + norbuprenorfiin |
es-ES | Spanish (Spain) | Buprenorfina+Norbuprenorfina |
it-IT | Italian (Italy) | Buprenorfina+Norbuprenorfina |
tr-TR | Turkish (Turkey) | Buprenorfin+Norbuprenorfin |
ru-RU | Russian (Russian Federation) | Бупренорфин+Норбупренорфин |
nl-NL | Dutch (Netherlands) | buprenorfine + norbuprenorfine |
fr-BE | French (Belgium) | Buprénorphine+Norbuprénorphine |
LOINC Copyright
Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://